908 Devices Azione

908 Devices EBITDA

Il EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) di 908 Devices (MASS) al 25 lug 2026 è -24,18 Mio. USD. L'anno precedente, EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) era -76,09 Mio. USD — una variazione del -68,22% (superiore).

EBITDA

-24,18 Mio.USD

YoY

-68,22%

Ultimo aggiornamento:

EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) di 908 Devices ammonta a 2026 -24,18 Mio. USD. EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) di 908 Devices ammontava a 2025 -76,09 Mio. USD. Diminuisce del -68,22% superiore rispetto all'anno precedente.
Access this data via the Eulerpool API

908 Devices Analisi delle Azioni

Cosa fa 908 Devices? The company 908 Devices was founded in Boston in 2012 and specializes in the development and manufacturing of innovative analysis devices. The idea behind the company was to develop portable devices that would allow users to perform quick and accurate analyses on-site. 908 Devices' business model is based on the development and marketing of devices for the chemistry, pharmaceutical, and biotech industries, as well as for applications in the security and defense sectors. The company has several product lines tailored to different applications, including portable devices for mobile use. One of the most important branches of 908 Devices is mass spectrometry, a method used in many areas of analytics, such as forensics, environmental analysis, and food control. 908 Devices has developed a technology that allows for compact and portable mass spectrometry, which was not previously possible. Another important area of 908 Devices is chromatography, a method used for separating substances. Here too, the company has developed a technology that allows for the offering of chromatography in portable devices. 908 Devices also offers devices for molecular spectroscopy, including Raman spectroscopy, which allows for the identification and characterization of molecules. Raman spectroscopy is used in many applications, such as pharmaceutical research and material analysis. Among the products offered by 908 Devices are the M908 and MX908 devices, specifically designed for use in the security and defense industry. These devices allow for the real-time detection of a variety of hazardous substances, such as explosives, drugs, or dangerous chemicals. Another product of 908 Devices is the ZipChip device, used in biotech research. The ZipChip allows for the analysis of proteins in a very short time, which is of great importance in pharmaceutical research. The company has received several awards in recent years, including the R&D 100 Award and the Innovation Award of Analytica, one of the world's most important trade fairs for analytics and laboratory technology. Overall, 908 Devices has achieved an impressive success story and aims to revolutionize the way analyses are conducted. With its innovative products and technologies, the company has found a niche in the market and has experienced strong growth. 908 Devices è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su 908 Devices azioni

EBITDA (Guadagni prima di interessi, tasse, ammortamenti e svalutazioni) di 908 Devices è -24,18 Mio. USD nel 2026.

Access this data via the Eulerpool API

Conto economico — 908 Devices

Tutte le Metriche Finanziarie — 908 Devices